Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
123.79
+1.18 (0.96%)
At close: Oct 31, 2025, 4:00 PM EDT
124.65
+0.86 (0.69%)
After-hours: Oct 31, 2025, 7:19 PM EDT
Novartis AG Analyst Ratings
Total Analysts
5
Consensus Rating
Hold
Price Target
$119.00
Upside
-3.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 27, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $119 → $118 | Hold → Strong Sell | Downgrades | $119 → $118 | -4.68% | Sep 12, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 13, 2025 |
| Erste Group | Erste Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 19, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $118 → $120 | Hold | Maintains | $118 → $120 | -3.06% | Oct 30, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $135 → $130 | Strong Buy → Hold | Downgrades | $135 → $130 | +5.02% | Sep 11, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $119 → $121 | Strong Buy → Hold | Downgrades | $119 → $121 | -2.25% | Sep 5, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 3, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $121 → $123 | Strong Buy | Maintains | $121 → $123 | -1.04% | Jul 2, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $114 → $116 | Hold | Maintains | $114 → $116 | -6.29% | Apr 24, 2024 |
| BMO Capital | BMO Capital | Hold Initiates $114 | Hold | Initiates | $114 | -7.91% | Feb 23, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $114 | Hold | Initiates | $114 | -7.91% | Jan 23, 2024 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Sep 25, 2023 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 9, 2022 |
| Exane BNP Paribas | Exane BNP Paribas | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 6, 2021 |
| Bryan Garnier | Bryan Garnier | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 3, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.